Spoerry C, Seele J, Valentin-Weigand P, Baums C, von Pawel-Rammingen U
J Biol Chem. 2016; 291(15):7915-25.
PMID: 26861873
PMC: 4824999.
DOI: 10.1074/jbc.M115.711440.
Laine D, Palovich M, McCleland B, Petitjean E, Delhom I, Xie H
ACS Med Chem Lett. 2014; 2(2):142-7.
PMID: 24900293
PMC: 4018094.
DOI: 10.1021/ml100212k.
Krauspe R, Scheer A, Schaper S, Bohley P
Planta. 2013; 167(4):482-90.
PMID: 24240364
DOI: 10.1007/BF00391224.
Robinson M, Corvo I, Jones P, George A, Padula M, To J
PLoS Negl Trop Dis. 2011; 5(4):e1012.
PMID: 21483711
PMC: 3071364.
DOI: 10.1371/journal.pntd.0001012.
Horn M, Nussbaumerova M, Sanda M, Kovarova Z, Srba J, Franta Z
Chem Biol. 2009; 16(10):1053-63.
PMID: 19875079
PMC: 2801564.
DOI: 10.1016/j.chembiol.2009.09.009.
Cathepsin K inhibitors for osteoporosis and potential off-target effects.
Bromme D, Lecaille F
Expert Opin Investig Drugs. 2009; 18(5):585-600.
PMID: 19388876
PMC: 3110777.
DOI: 10.1517/13543780902832661.
Profiling of proteolytic enzymes in the gut of the tick Ixodes ricinus reveals an evolutionarily conserved network of aspartic and cysteine peptidases.
Sojka D, Franta Z, Horn M, Hajdusek O, Caffrey C, Mares M
Parasit Vectors. 2008; 1(1):7.
PMID: 18348719
PMC: 2289814.
DOI: 10.1186/1756-3305-1-7.
Structural and functional relationships in the virulence-associated cathepsin L proteases of the parasitic liver fluke, Fasciola hepatica.
Stack C, Caffrey C, Donnelly S, Seshaadri A, Lowther J, Tort J
J Biol Chem. 2007; 283(15):9896-908.
PMID: 18160404
PMC: 3979170.
DOI: 10.1074/jbc.M708521200.
The crystal structure of human dipeptidyl peptidase I (cathepsin C) in complex with the inhibitor Gly-Phe-CHN2.
Molgaard A, Arnau J, Lauritzen C, Larsen S, Petersen G, Pedersen J
Biochem J. 2006; 401(3):645-50.
PMID: 17020538
PMC: 1770842.
DOI: 10.1042/BJ20061389.
Irreversible inhibition of the bacterial cysteine protease-transpeptidase sortase (SrtA) by substrate-derived affinity labels.
Scott C, McDowell A, Martin S, Lynas J, Vandenbroeck K, Walker B
Biochem J. 2002; 366(Pt 3):953-8.
PMID: 12069686
PMC: 1222829.
DOI: 10.1042/BJ20020602.
IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G.
von Pawel-Rammingen U, Johansson B, Bjorck L
EMBO J. 2002; 21(7):1607-15.
PMID: 11927545
PMC: 125946.
DOI: 10.1093/emboj/21.7.1607.
Free-thiol Cys331 exposed during activation process is critical for native tetramer structure of cathepsin C (dipeptidyl peptidase I).
Horn M, Baudys M, Voburka Z, Kluh I, Vondrasek J, Mares M
Protein Sci. 2002; 11(4):933-43.
PMID: 11910036
PMC: 2384168.
DOI: 10.1110/ps.2910102.
The endosomal-lysosomal system of neurons in Alzheimer's disease pathogenesis: a review.
Nixon R, Cataldo A, Mathews P
Neurochem Res. 2000; 25(9-10):1161-72.
PMID: 11059790
DOI: 10.1023/a:1007675508413.
Quantification of cathepsins B and L in cells.
Xing R, Addington A, Mason R
Biochem J. 1998; 332 ( Pt 2):499-505.
PMID: 9601080
PMC: 1219506.
DOI: 10.1042/bj3320499.
A Trypanosoma cruzi-secreted 80 kDa proteinase with specificity for human collagen types I and IV.
Santana J, Grellier P, Schrevel J, Teixeira A
Biochem J. 1997; 325 ( Pt 1):129-37.
PMID: 9224638
PMC: 1218537.
DOI: 10.1042/bj3250129.
Suppression of cathepsins B and L causes a proliferation of lysosomes and the formation of meganeurites in hippocampus.
Bednarski E, Ribak C, Lynch G
J Neurosci. 1997; 17(11):4006-21.
PMID: 9151717
PMC: 6573562.
Biotin-labelled peptidyl diazomethane inhibitors derived from the substrate-like sequence of cystatin: targeting of the active site of cruzipain, the major cysteine proteinase of Trypanosoma cruzi.
Lalmanach G, Mayer R, Serveau C, Scharfstein J, Gauthier F
Biochem J. 1996; 318 ( Pt 2):395-9.
PMID: 8809025
PMC: 1217635.
DOI: 10.1042/bj3180395.
Conserved cystatin segments as models for designing specific substrates and inhibitors of cysteine proteinases.
Lalmanach G, Serveau C, Chagas J, Mayer R, Juliano L, Gauthier F
J Protein Chem. 1995; 14(8):645-53.
PMID: 8747425
DOI: 10.1007/BF01886903.
Investigation of the substrate specificity of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, through the use of cystatin-derived substrates and inhibitors.
Serveau C, Lalmanach G, Juliano M, Scharfstein J, Juliano L, Gauthier F
Biochem J. 1996; 313 ( Pt 3):951-6.
PMID: 8611180
PMC: 1217003.
DOI: 10.1042/bj3130951.
Expression and partial characterization of a cathepsin B-like enzyme (Sm31) and a proposed 'haemoglobinase' (Sm32) from Schistosoma mansoni.
Gotz B, Klinkert M
Biochem J. 1993; 290 ( Pt 3):801-6.
PMID: 8457210
PMC: 1132352.
DOI: 10.1042/bj2900801.
